<?xml version='1.0' encoding='UTF-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" 
         xmlns:bmdb="http://edrn.nci.nih.gov/rdf/rdfs/bmdb-1.0.0#"
         xmlns:edrn="http://edrn.nci.nih.gov/rdf/schema.rdf#"
         xmlns:edrntype="http://edrn.nci.nih.gov/rdf/types.rdf#" 
         xmlns:dc="http://purl.org/dc/terms/">
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/32">
    <bmdb:Title>Annexin 1</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:32</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:32</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Annexin 1 belongs to a family of calcium-dependent phospholipid binding proteins which are preferentially located on the cytosolic face of the plasma membrane. Annexin I protein has an apparent relative molecular mass of 40 kDa, with phospholipase A2 inhibitory activity.  Since phospholipase A2 is required for the biosynthesis of the potent mediators of inflammation, prostaglandins and leukotrienes, annexin I may have potential anti-inflammatory activity. Annexin 1 also promotes membrane fusion and is involved in exocytosis. It seems to bind from two to four calcium ions with high affinity.</bmdb:Description>
    <bmdb:QAState>Accepted</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Chromobindin-9 </bmdb:Alias>
    <bmdb:Alias>ANXA1</bmdb:Alias>
    <bmdb:Alias>ANX1</bmdb:Alias>
    <bmdb:Alias>LPC1</bmdb:Alias>
    <bmdb:Alias>Lipocortin I</bmdb:Alias>
    <bmdb:Alias>Calpactin II</bmdb:Alias>
    <bmdb:Alias>p35</bmdb:Alias>
    <bmdb:Alias>Phospholipase A2 inhibitory protein </bmdb:Alias>
    <bmdb:Alias>Annexin A1</bmdb:Alias>
    <bmdb:Alias>Annexin-1</bmdb:Alias>
    <bmdb:Alias>Annexin I</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/39"/>
    <bmdb:AccessGrantedTo>Lung and Upper Aerodigestive</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/32/53"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/32/18">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/138"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/25"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/26"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <bmdb:referencesResource rdf:resource="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&amp;id=4502101"/>
    <bmdb:referencesResource rdf:resource="http://ca.expasy.org/uniprot/P04083"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=533"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:301"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/20">
    <bmdb:Title>CA125</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:20</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:20</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>CA125 is a highly glycosylated sialomucin that is expressed on epithelial cell surface, especially on ovarian cancer cells.  CA 125 is anchored to the epithelium by a transmembrane domain and is released into the extracellular space by enzymatic cleavage. It is thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces.
</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>FLJ14303</bmdb:Alias>
    <bmdb:Alias>Mucin 16</bmdb:Alias>
    <bmdb:Alias>Mucin-16</bmdb:Alias>
    <bmdb:Alias>MUC-16</bmdb:Alias>
    <bmdb:Alias>Ovarian carcinoma antigen CA125</bmdb:Alias>
    <bmdb:Alias>Ovarian cancer-related tumor marker CA125</bmdb:Alias>
    <bmdb:Alias>CA-125 </bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Breast and Gynecologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/20/41"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/55">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/20/30">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/8"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/35"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.ad.jp/dbget-bin/www_bget?hsa+94025"/>
    <bmdb:referencesResource rdf:resource="http://ca.expasy.org/uniprot/Q8WXI7"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=15582"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/19">
    <bmdb:Title>DCP</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:19</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:19</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Des-gamma-carboxy Prothrombin (DCP) is a non-functional precursor of prothrombin.  Prothrombin, produced by the liver, serves a critical role in normal hemostasis. Functional prothrombin contains several gamma-carboxy-glutamic acid (Gla) residues that are produced as the result of post-translational modification of glutamic acid residues mediated by vitamin K dependent gamma-glutamyl carboxylase. The formation of Gla residues can be impaired in patients with vitamin K deficiency or in patients receiving oral anticoagulant therapy. DCP lacks thrombotic activity and has been shown in multiple studies to be present in the serum of patients with HCC. DCP arises from an acquired defect in the post-translational carboxylation of the pro-thrombin precursor in malignant hepatocytes.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Des-gamma carboxyprothrombin</bmdb:Alias>
    <bmdb:Alias>Prothrombin Induced by Vitamin K Absence II</bmdb:Alias>
    <bmdb:Alias>PIVKA II</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/19/40"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/19/21">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/111"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/23"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/33"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/34"/>
    <bmdb:referencesResource rdf:resource="http://www.med.umich.edu/gi/staff/Marrero.htm"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/21">
    <bmdb:Title>KLK-6</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:21</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:21</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Serine protease M expressed on epithelial cell surface and released in ECM. Tumor cells treated with a neutralizing KLK6 antibody migrate less than control cells, suggesting a role in invasion and metastasis. Overexpressed in primary breast tumors but not expressed in metastatic tumors.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Kallikrein-6</bmdb:Alias>
    <bmdb:Alias>HK-6</bmdb:Alias>
    <bmdb:Alias>Protease M</bmdb:Alias>
    <bmdb:Alias>Neurosin</bmdb:Alias>
    <bmdb:Alias>Serine protease 9</bmdb:Alias>
    <bmdb:Alias>Serine protease 18</bmdb:Alias>
    <bmdb:Alias>Zyme</bmdb:Alias>
    <bmdb:Alias>SP59</bmdb:Alias>
    <bmdb:Alias>Bssp</bmdb:Alias>
    <bmdb:Alias>PRSS9</bmdb:Alias>
    <bmdb:Alias>PRSS18</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Breast and Gynecologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/21/42"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/21/15">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/21/43">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/9"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6367"/>
    <bmdb:referencesResource rdf:resource="http://www.expasy.org/cgi-bin/niceprot.pl?Q92876"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:5653"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/22">
    <bmdb:Title>CA72-4</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:22</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:22</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>High-MW mucin-type glycoprotein expressed on epithelial cancer cells.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>tumor-associated glycoprotein 72</bmdb:Alias>
    <bmdb:Alias>TAG-72</bmdb:Alias>
    <bmdb:Alias>Cancer-associated Antigen 72-4</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Breast and Gynecologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/22/43"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/22/32">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/22/33">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/10"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/23">
    <bmdb:Title>B7-H4</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:23</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:23</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Highly glycosylated sialomucin; expressed on immune cells.  Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation. Overexpressed in breast, ovarian, endometrial, renal cell (RCC) and non-small-cell lung cancers (NSCLC).  Belongs to the B7 family of costimulatory proteins.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Immune costimulatory protein B7-H4</bmdb:Alias>
    <bmdb:Alias>B7h.5</bmdb:Alias>
    <bmdb:Alias>T-cell costimulatory molecule B7x </bmdb:Alias>
    <bmdb:Alias>Protein B7S1</bmdb:Alias>
    <bmdb:Alias>VTCN1</bmdb:Alias>
    <bmdb:Alias>B7H4</bmdb:Alias>
    <bmdb:Alias>V-set domain containing T cell activation inhibitor 1</bmdb:Alias>
    <bmdb:Alias>OV110</bmdb:Alias>
    <bmdb:Alias>DD-0110</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Breast and Gynecologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/23/44"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/23/39">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/23/40">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/11"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=28873"/>
    <bmdb:referencesResource rdf:resource="http://www.expasy.org/uniprot/Q7Z7D3"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:79679"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/24">
    <bmdb:Title>HE4</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:24</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:24</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>11 kDa protein that is a precursor to the epididymal secretory protein HE4; an inhibitor of an as yet unidentified protease.  Highly expressed in a number of tumors cells lines, such ovarian, colon, breast, lung and renal cells lines.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>WAP four-disulfide core domain 2 [Precursor]</bmdb:Alias>
    <bmdb:Alias>WFDC2</bmdb:Alias>
    <bmdb:Alias>WAP5</bmdb:Alias>
    <bmdb:Alias>Major epididymis-specific protein E4 </bmdb:Alias>
    <bmdb:Alias>Epididymal secretory protein E4</bmdb:Alias>
    <bmdb:Alias>Putative protease inhibitor WAP5 </bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Breast and Gynecologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/24/45"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/41">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/24/42">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/12"/>
    <bmdb:referencesResource rdf:resource="http://www.expasy.org/uniprot/Q14508"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=15939"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:10406"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/25">
    <bmdb:Title>CA 19-9</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:25</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:25</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>CA19-9 may be a molecular marker for ovarian cancer.  Literature suggests that the concomitant measurement of CA19-9 with CA125 could offer some benefit in the monitoring of patients for the recurrence of ovarian carcinoma.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Breast and Gynecologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/25/46"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/34">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/25/35">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/13"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/14"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/26">
    <bmdb:Title>CA 15-3</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:26</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:26</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>
CA15-3 may be a molecular marker for ovarian cancer. Literature suggests that the concomitant measurement of CA15-3 with CA125 could be advantageous in the pre-operative discrimination of benign and malignant ovarian tumors.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Breast and Gynecologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/26/47"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/37">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/26/38">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/15"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/16"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/17"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/27">
    <bmdb:Title>Osteopontin</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:27</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:27</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Osteopontin (OPN), a secreted, integrin-binding matrix phosphorylated glycoprotein is involved in bone remodeling by osteoclasts and is overexpressed in many advanced cancers. Osteopontin (OPN) has been identified as one of the leading genes that promotes the metastasis of hepatocellular carcinoma.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Bone sialoprotein 1</bmdb:Alias>
    <bmdb:Alias>Secreted phosphoprotein 1</bmdb:Alias>
    <bmdb:Alias>SPP-1</bmdb:Alias>
    <bmdb:Alias>Urinary stone protein</bmdb:Alias>
    <bmdb:Alias>Nephropontin</bmdb:Alias>
    <bmdb:Alias>Uropontin</bmdb:Alias>
    <bmdb:Alias>BNSP</bmdb:Alias>
    <bmdb:Alias>OPN</bmdb:Alias>
    <bmdb:Alias>BSPI</bmdb:Alias>
    <bmdb:Alias>ETA-1</bmdb:Alias>
    <bmdb:Alias>early T-lymphocyte activation 1</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/27/48"/>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/27/100"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/18"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/21"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/43"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/48"/>
    <bmdb:referencesResource rdf:resource="http://expasy.org/uniprot/P10451"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:6696"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11255"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/28">
    <bmdb:Title>SMRP</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:28</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:28</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>SMRP is a transmembrane protein.  It acts as a multispecific organic anion pump which can transport nucleotide analogs.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>MRP5</bmdb:Alias>
    <bmdb:Alias>ATP-binding cassette sub-family C member 5</bmdb:Alias>
    <bmdb:Alias>Multi-specific organic anion transporter-C</bmdb:Alias>
    <bmdb:Alias>MOAT-C</bmdb:Alias>
    <bmdb:Alias>pABC11</bmdb:Alias>
    <bmdb:Alias>Multidrug resistance-associated protein 5</bmdb:Alias>
    <bmdb:Alias>ABCC5</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/28/49"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/7"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/42"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/43"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=56"/>
    <bmdb:referencesResource rdf:resource="http://www.expasy.org/cgi-bin/niceprot.pl?O15440"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/29">
    <bmdb:Title>MMP9</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:29</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:29</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Secreted protein may play an essential role in local proteolysis of the extracellular matrix and in leukocyte migration.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>92 kDa type IV collagenase</bmdb:Alias>
    <bmdb:Alias>Gelatinase B</bmdb:Alias>
    <bmdb:Alias>GELB</bmdb:Alias>
    <bmdb:Alias>CLG4B</bmdb:Alias>
    <bmdb:Alias>metalloproteinase-9 [Precursor]</bmdb:Alias>
    <bmdb:Alias>92kDa gelatinase</bmdb:Alias>
    <bmdb:Alias>matrix metallopeptidase 9</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/29/50"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/20"/>
    <bmdb:referencesResource rdf:resource="http://www.expasy.org/uniprot/P14780"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:4318"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7176"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/30">
    <bmdb:Title>CRTL1</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:30</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:30</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>This widely expressed protein stabilizes the aggregates of proteoglycan monomers with hyaluronic acid in the extracellular cartilage matrix.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>HPLN1</bmdb:Alias>
    <bmdb:Alias>Proteoglycan link protein</bmdb:Alias>
    <bmdb:Alias>Cartilage link protein</bmdb:Alias>
    <bmdb:Alias>LP</bmdb:Alias>
    <bmdb:Alias>Hyaluronan and proteoglycan link protein 1 [Precursor]</bmdb:Alias>
    <bmdb:Alias>cartilage linking protein 1</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/30/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/22"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=2380"/>
    <bmdb:referencesResource rdf:resource="http://ca.expasy.org/cgi-bin/niceprot.pl?P10915"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:1404"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/34">
    <bmdb:Title>14-3-3 theta</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:34</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:34</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>14-3-3 theta belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 99% identical to the mouse and rat orthologs. The 14-3-3 proteins have a wide range of ligands, are involved in a variety of biological pathways, and are known to be overexpressed in some human lung cancers, suggesting that they may play a role in tumorigenesis. 14-3-3 theta is an adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathway. It binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner.  14-3-3 theta antigens have been found to be targets of autoantibodies in subjects newly diagnosed with lung cancer.</bmdb:Description>
    <bmdb:QAState>Accepted</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>14-3-3 protein theta</bmdb:Alias>
    <bmdb:Alias>14-3-3 protein tau</bmdb:Alias>
    <bmdb:Alias>14-3-3 protein T-cell</bmdb:Alias>
    <bmdb:Alias>Protein HS1</bmdb:Alias>
    <bmdb:Alias>YWHAQ</bmdb:Alias>
    <bmdb:Alias>tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta po</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/39"/>
    <bmdb:AccessGrantedTo>Lung and Upper Aerodigestive</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/34/54"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/34/19">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/138"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/28"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/29"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/30"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <bmdb:referencesResource rdf:resource="http://ca.expasy.org/uniprot/P27348"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12854"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:10971"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/31">
    <bmdb:Title>Microsatellite Instability Assay</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:31</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:31</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Microsatellite analysis (MSA) is a promising new technique for the surveillance of bladder cancer.  The technology, which permits the separation by electrophoresis of polymerase chain reaction (PCR)-amplified sequences from non-malignant and malignant sources, has been applied to the diagnosis of solid tumors arising in colon, lung, oropharynx, kidney and bladder.

MSA can detect genetic changes indicative of carcinoma from urothelial cells obtained in voided urine specimens.  The genetic profile of DNA purified from urine is compared to that of DNA purified from peripheral lymphocytes that are considered &amp;quot;normal.&amp;quot;  Once the DNA from uroepithelial cells has been obtained, PCR is performed with specific oligonucleotide primers for each chromosomal locus.  The PCR products are then examined for evidence of microsatellite instability (MSI) and loss of heterozygosity (LOH), which are genetic characteristics of epithelial tumors.  Preliminary work shows that MSA detects 95% of cancers.
</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genetic</bmdb:Type>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/31/52"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/31/16">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/108"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/24"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/35">
    <bmdb:Title>LAMR1</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:35</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:35</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes.  They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Many of the effects of laminin are mediated through interactions with cell surface receptors. These receptors include members of the integrin family, as well as non-integrin laminin-binding proteins. The amino acid sequence of laminin receptor 1 is highly through evolution, suggesting a key biological function. It has been observed that the level of the laminin receptor transcript is higher in colon carcinoma tissue and lung cancer cell line than their normal counterparts. Also, there is a correlation between the upregulation of this polypeptide in cancer cells and their invasive and metastatic phenotype.  Cell-adhesive protein LAMR1 plays an important role in the processes of cancer proliferation, invasion and metastasis.  LAMR1 antigens have been found to be targets of autoantibodies in subjects newly diagnosed with lung cancer.</bmdb:Description>
    <bmdb:QAState>Accepted</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>RPSA</bmdb:Alias>
    <bmdb:Alias>ribosomal protein SA</bmdb:Alias>
    <bmdb:Alias>laminin receptor 1</bmdb:Alias>
    <bmdb:Alias>laminin receptor 1 (67kD, ribosomal protein SA)</bmdb:Alias>
    <bmdb:Alias>LRP</bmdb:Alias>
    <bmdb:Alias>37LRP</bmdb:Alias>
    <bmdb:Alias>p40</bmdb:Alias>
    <bmdb:Alias>34/67 kDa laminin receptor </bmdb:Alias>
    <bmdb:Alias>LamR</bmdb:Alias>
    <bmdb:Alias>Colon carcinoma laminin-binding protein</bmdb:Alias>
    <bmdb:Alias>NEM/1CHD4</bmdb:Alias>
    <bmdb:Alias>Multidrug resistance-associated protein MGr1-Ag</bmdb:Alias>
    <bmdb:Alias>LAMBR</bmdb:Alias>
    <bmdb:Alias>RSSA</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/39"/>
    <bmdb:AccessGrantedTo>Lung and Upper Aerodigestive</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/35/55"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/35/20">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/138"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/28"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/76"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/77"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/78"/>
    <bmdb:referencesResource rdf:resource="http://ca.expasy.org/cgi-bin/niceprot.pl?Q86VC0"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6502"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:3921"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/36">
    <bmdb:Title>AFP</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:36</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:36</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>AFP is a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistance of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Private</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Alpha-fetoglobulin</bmdb:Alias>
    <bmdb:Alias>FETA</bmdb:Alias>
    <bmdb:Alias>Alpha-1-fetoprotein</bmdb:Alias>
    <bmdb:Alias>Alpha-fetoprotein</bmdb:Alias>
    <bmdb:Alias>OTTHUMP00000160480</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/36/56"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/33"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=317"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P02771"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:174"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/37">
    <bmdb:Title>AFP-L3</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:37</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:37</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>AFP-L3 is an isoform of AFP, a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. The L3 isoform is specific to malignant tumors and its detected presence may serve to identify patients who could benefit from monitoring for the development of HCC in high risk populations (i.e. chronic hepatitis, liver cirrhosis).</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Lectin-bound alpha-fetoprotein</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/37/57"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/33"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/36"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/37"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/38"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/38">
    <bmdb:Title>PGP9.5</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:38</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:38</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>PGP9.5, also called Ubiquitin-protein hydrolase (UCHL1), is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. Expression of UCHL1 is highly specific to neurons and to cells of the diffuse neuroendocrine system and their tumors. This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. Oxidation of Met-1, Met-6, Met-12, Met-124 and Met-179 to methionine sulfoxide, and oxidation of Cys-220 to cysteine sulfonic acid have been observed in brains from Alzheimer disease (AD) and Parkinson disease (PD) patients. PGP9.5 has been proposed as a marker with a potential role in carcinogenesis.</bmdb:Description>
    <bmdb:QAState>Accepted</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>UCHL1</bmdb:Alias>
    <bmdb:Alias>ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)</bmdb:Alias>
    <bmdb:Alias>Uch-L1</bmdb:Alias>
    <bmdb:Alias>PARK5</bmdb:Alias>
    <bmdb:Alias>Neuron cytoplasmic protein 9.5</bmdb:Alias>
    <bmdb:Alias>UCH-L1</bmdb:Alias>
    <bmdb:AccessGrantedTo>Lung and Upper Aerodigestive</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/38/59"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/26"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/39"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/40"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/41"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/75"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P09936"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=12513"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:7345"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/39">
    <bmdb:Title>Hanash 3-marker panel for Lung Cancer</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:39</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:39</bmdb:URN>
    <bmdb:IsPanel>1</bmdb:IsPanel>
    <bmdb:Description>The EDRN validation study (&amp;quot;Validation of Protein Markers for Lung Cancer Using CARET Sera and Proteomics Techniques&amp;quot;) presents evidence for the occurrence in lung cancer sera of autoantibodies to annexin 1, 14-3-3 theta and LAMR1, which precede the onset of symptoms and diagnosis.  The combined AUC for these three antigens in CARET pre-clinical lung cancer sera vs. matched controls was 0.73. While autoantibodies to various cancer antigens have been reported in newly diagnosed lung cancer patient sera, an important aspect of this study is testing for occurrence of autoantibodies in pre-diagnostic sera and demonstration of significant autoantibody reactivity against LAMR1, annexin 1 and 14-3-3 theta.</bmdb:Description>
    <bmdb:QAState>Accepted</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/32"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/34"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/35"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Lung and Upper Aerodigestive</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/39/60"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/27"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/41">
    <bmdb:Title>DJ-1</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:41</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:41</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>DJ-1, also known as PARK-7, belongs to the peptidase C56 family of proteins. It acts as a positive regulator of androgen receptor-dependent transcription. It may also function as a redox-sensitive chaperone, as a sensor for oxidative stress, and it apparently protects neurons against oxidative stress and cell death. DJ-1 is highly expressed in pancreas, kidney, skeletal muscle, liver, testis and heart and is detected at slightly lower levels in placenta and brain.</bmdb:Description>
    <bmdb:QAState>Accepted</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>PARK7</bmdb:Alias>
    <bmdb:Alias>Protein DJ-1</bmdb:Alias>
    <bmdb:Alias>Oncogene DJ-1</bmdb:Alias>
    <bmdb:Alias>Parkinson disease protein 7</bmdb:Alias>
    <bmdb:Alias>DJ1</bmdb:Alias>
    <bmdb:Alias>Parkinson disease (autosomal recessive, early onset) 7</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Lung and Upper Aerodigestive</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/41/62"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/44"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/73"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/74"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q99497"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=16369"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:11315"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/42">
    <bmdb:Title>SCCA</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:42</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:42</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Squamous cell carcinoma antigen (SCCA) may act as a protease inhibitor to modulate the host immune response against tumor cells.  Present in the cytoplasm of squamous cells, also secreted in plasma in some hepatocellular carcinoma but at low protein level.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Squamous cell carcinoma antigen 1</bmdb:Alias>
    <bmdb:Alias>SCCA-1</bmdb:Alias>
    <bmdb:Alias>SERPINB3</bmdb:Alias>
    <bmdb:Alias>SCCA1</bmdb:Alias>
    <bmdb:Alias>Protein T4-A</bmdb:Alias>
    <bmdb:Alias>SPB3</bmdb:Alias>
    <bmdb:Alias>serpin peptidase inhibitor, clade B (ovalbumin), member 3</bmdb:Alias>
    <bmdb:Alias>HsT1196</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/42/63"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/45"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/46"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/47"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P29508"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=10569"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:6317"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/43">
    <bmdb:Title>SCCAIC</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:43</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:43</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>SCCAIC, squamous cellular carcinoma antigen (SCCA) immunocomplexed with IgM, has been proposed as an alternative marker. Squamous cell carcinoma antigen (SCCA) may act as a protease inhibitor to modulate the host immune response against tumor cells. It is present in the cytoplasm of squamous cells and is also secreted in plasma in some hepatocellular carcinoma, but at low protein level.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>SCCA immunocomplexed with IgM</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/43/64"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/44">
    <bmdb:Title>AFPIC</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:44</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:44</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>AFP is a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistance of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. AFPIC is AFP immunocomplexed with IgM, a potential alternative marker for hepatocellular cancer.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/44/65"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/45">
    <bmdb:Title>CDH13</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:45</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:45</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>CDH13 is a member of the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region but, unlike the typical cadherin superfamily member, lacks the highly conserved cytoplasmic region. This particular cadherin is a putative mediator of cell-cell interaction in the heart and may act as a negative regulator of neural cell growth. The gene locus is hypermethylated or deleted in breast, ovarian and lung cancers.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:Alias>cadherin 13</bmdb:Alias>
    <bmdb:Alias>H-cadherin (heart)</bmdb:Alias>
    <bmdb:Alias>P105</bmdb:Alias>
    <bmdb:Alias>T-cad</bmdb:Alias>
    <bmdb:Alias>H-cadherin</bmdb:Alias>
    <bmdb:Alias>T-cadherin</bmdb:Alias>
    <bmdb:Alias>heart-cadherin</bmdb:Alias>
    <bmdb:Alias>truncated-cadherin</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <bmdb:AccessGrantedTo>GI and Other Associated</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/45/66"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/45/44">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/49"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/50"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=1753"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P55290"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:1012"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/47">
    <bmdb:Title>TAC1</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:47</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:47</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>The tachykinin gene encodes four products of the tachykinin peptide hormone family, substance P and neurokinin A, as well as the related peptides, neuropeptide K and neuropeptide gamma. These active peptides are thought to function as neurotransmitters which interact with nerve receptors and smooth muscle cells. They are known to induce behavioral responses and function as vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles. Multiple transcript variants encoding different isoforms have been found for this gene.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:Alias>tachykinin-1</bmdb:Alias>
    <bmdb:Alias>tachykinin, precursor 1</bmdb:Alias>
    <bmdb:Alias>neurokinin 1</bmdb:Alias>
    <bmdb:Alias>neurokinin 2</bmdb:Alias>
    <bmdb:Alias>neuromedin L</bmdb:Alias>
    <bmdb:Alias>neurokinin alpha</bmdb:Alias>
    <bmdb:Alias>neuropeptide K</bmdb:Alias>
    <bmdb:Alias>neuropeptide gamma</bmdb:Alias>
    <bmdb:Alias>NPK</bmdb:Alias>
    <bmdb:Alias>TKN1</bmdb:Alias>
    <bmdb:Alias>PPT</bmdb:Alias>
    <bmdb:Alias>Protachykinin-1</bmdb:Alias>
    <bmdb:Alias>TAC2</bmdb:Alias>
    <bmdb:Alias>NKNA</bmdb:Alias>
    <bmdb:Alias>substance P</bmdb:Alias>
    <bmdb:Alias>substance K</bmdb:Alias>
    <bmdb:Alias>tachykinin</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>GI and Other Associated</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/47/68"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/47/46">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/60"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/62"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/63"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P20366"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:6863"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11517"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/48">
    <bmdb:Title>p16</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:48</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:48</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, MDM1, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:Alias>CDKN2A</bmdb:Alias>
    <bmdb:Alias>CDKN2</bmdb:Alias>
    <bmdb:Alias>MTS1</bmdb:Alias>
    <bmdb:Alias>Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3</bmdb:Alias>
    <bmdb:Alias>Cyclin-dependent kinase 4 inhibitor A</bmdb:Alias>
    <bmdb:Alias>p16-INK4a</bmdb:Alias>
    <bmdb:Alias>Multiple tumor suppressor 1</bmdb:Alias>
    <bmdb:Alias>CDK4I</bmdb:Alias>
    <bmdb:Alias>INK4a</bmdb:Alias>
    <bmdb:Alias>CMM2</bmdb:Alias>
    <bmdb:Alias>ARF</bmdb:Alias>
    <bmdb:Alias>p19</bmdb:Alias>
    <bmdb:Alias>p14</bmdb:Alias>
    <bmdb:Alias>INK4</bmdb:Alias>
    <bmdb:Alias>p16INK4a</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/90"/>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/91"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>GI and Other Associated</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/48/71"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/48/47">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/53"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/64"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/65"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P42771"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=1787"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/46">
    <bmdb:Title>NELL1</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:46</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:46</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>NELL1 is a cytoplasmic protein that contains epidermal growth factor (EGF)-like repeats. The encoded heterotrimeric protein may be involved in cell growth regulation and differentiation.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:Alias>Protein kinase C-binding protein NELL1</bmdb:Alias>
    <bmdb:Alias>NEL-like protein 1</bmdb:Alias>
    <bmdb:Alias>Nel-related protein 1</bmdb:Alias>
    <bmdb:Alias>NRP1</bmdb:Alias>
    <bmdb:Alias>nel-like 1</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>GI and Other Associated</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/46/67"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/46/45">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/52"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q92832"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=7750"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:4745"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/49">
    <bmdb:Title>RUNX3</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:49</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:49</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>RUNX3 is a member of the runt domain-containing family of transcription factors. A heterodimer of this protein and a beta subunit forms a complex that binds to the core DNA sequence 5&amp;apos;-PYGPYGGT-3&amp;apos; found in a number of enhancers and promoters, and can either activate or suppress transcription. It also interacts with other transcription factors. It functions as a tumor suppressor, and the gene is frequently deleted or transcriptionally silenced in cancer. Multiple transcript variants encoding different isoforms have been found for this gene.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:Alias>Runt-related transcription factor 3</bmdb:Alias>
    <bmdb:Alias>Core-binding factor subunit alpha-3</bmdb:Alias>
    <bmdb:Alias>CBF-alpha-3</bmdb:Alias>
    <bmdb:Alias>Acute myeloid leukemia 2 protein</bmdb:Alias>
    <bmdb:Alias>Oncogene AML-2</bmdb:Alias>
    <bmdb:Alias>Polyomavirus enhancer-binding protein 2 alpha C subunit</bmdb:Alias>
    <bmdb:Alias>PEBP2-alpha C</bmdb:Alias>
    <bmdb:Alias>PEA2-alpha C</bmdb:Alias>
    <bmdb:Alias>SL3-3 enhancer factor 1 alpha C subunit</bmdb:Alias>
    <bmdb:Alias>SL3/AKV core-binding factor alpha C subunit</bmdb:Alias>
    <bmdb:Alias>AML2</bmdb:Alias>
    <bmdb:Alias>CBFA3</bmdb:Alias>
    <bmdb:Alias>PEBP2A3</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/90"/>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/91"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>GI and Other Associated</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/49/69"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/49/48">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/49"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/53"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q13761"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=10473"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:864"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/50">
    <bmdb:Title>HPP1</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:50</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:50</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>HPP1 (also called TMEFF2) may be a survival factor for hippocampal and mesencephalic neurons. The shedded form (generated by proteolytic shedding) up-regulates cancer cell proliferation, probably by promoting ERK1/2 phosphorylation. HPP1 is down-regulated in tumor cell lines in response to a high level of methylation in the 5&amp;apos; region. The CpG island methylation correlates with HPP1 silencing in tumor cell lines.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:Alias>TMEFF2 </bmdb:Alias>
    <bmdb:Alias>TENB2</bmdb:Alias>
    <bmdb:Alias>TR</bmdb:Alias>
    <bmdb:Alias>TPEF</bmdb:Alias>
    <bmdb:Alias>tomoregulin</bmdb:Alias>
    <bmdb:Alias>transmembrane protein TENB2</bmdb:Alias>
    <bmdb:Alias>transmembrane protein with EGF-like and two follistatin-like domains 2</bmdb:Alias>
    <bmdb:Alias>Tomoregulin-2</bmdb:Alias>
    <bmdb:Alias>Hyperplastic polyposis protein 1</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/90"/>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/91"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>GI and Other Associated</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/50/70"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/50/49">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/49"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/53"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/57"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/58"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11867"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9UIK5"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:23671"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/51">
    <bmdb:Title>SST</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:51</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:51</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>The hormone somatostatin (SST) has active 14 aa and 28 aa forms that are produced by alternate cleavage of the single preproprotein encoded by this gene. Somatostatin is expressed throughout the body and inhibits the release of numerous secondary hormones by binding to high-affinity G-protein-coupled somatostatin receptors. This hormone is an important regulator of the endocrine system through its interactions with pituitary growth hormone, thyroid stimulating hormone, and most hormones of the gastrointestinal tract. Somatostatin also affects rates of neurotransmission in the central nervous system and proliferation of both normal and tumorigenic cells. The promoter of somatostatin, a primary inhibitor of gastrin-stimulated gastric acid secretion, is hypermethylated in 80% of human colon cancers. A synthetic analog of SST, known as octreotide or SMS 201-995, is available under the name Sandostatin (Novartis). It is used for the treatment of a variety of disorders including acromegaly and the symptomatic treatment of carcinoid tumors and vasoactive intestinal peptide tumors.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:Alias>somatostatin</bmdb:Alias>
    <bmdb:Alias>Growth hormone release-inhibiting factor</bmdb:Alias>
    <bmdb:Alias>Somatostatin-28</bmdb:Alias>
    <bmdb:Alias>Somatostatin-14</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>GI and Other Associated</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/51/72"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/51/50">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/55"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/60"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P61278"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11329"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:6750"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/52">
    <bmdb:Title>AKAP12</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:52</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:52</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>AKAP12 is a member of the A-kinase anchor protein (AKAP) family, a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. AKAP12 is expressed in endothelial cells, cultured fibroblasts, and osteosarcoma cells. It associates with protein kinases A and C and phosphatase, and serves as a scaffold protein in signal transduction. This protein and RII PKA colocalize at the cell periphery. AKAP12 is a cell growth-related protein. Antibodies to this protein can be produced by patients with myasthenia gravis. Alternative splicing of this gene results in two transcript variants encoding different isoforms.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:Alias>A-kinase anchor protein 12</bmdb:Alias>
    <bmdb:Alias>Gravin</bmdb:Alias>
    <bmdb:Alias>Myasthenia gravis autoantigen</bmdb:Alias>
    <bmdb:Alias>A-kinase anchor protein 250 kDa</bmdb:Alias>
    <bmdb:Alias>AKAP250</bmdb:Alias>
    <bmdb:memberOfPanel rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>GI and Other Associated</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/52/73"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/52/51">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/59"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/60"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/61"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=370"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q02952"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:9590"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53">
    <bmdb:Title>Meltzer 8-marker panel for Esophageal Adenocarcinoma</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:53</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:53</bmdb:URN>
    <bmdb:IsPanel>1</bmdb:IsPanel>
    <bmdb:Description>Eight methylation biomarkers - p16, RUNX3, HPP1, NELL1, TAC1, SST, AKAP12 and CDH13 - were tested in a restrospective multicenter double-blinded validation study for their accuracy in predicting neoplastic progression in Barrett&amp;apos;s Esophagus. Hypermethylation of p16, RUNX3 and HPP1 has been show to occur in early Barrett&amp;apos;s Esophagus-related neoplastic progression and predicts progression risk. Several of the panel (NELL1, TAC1, SST, AKAP12 and CDH13) were also shown to be methylated early and often in Barrett&amp;apos;s Esophagus-related neoplastic progression.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/45"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/46"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/47"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/48"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/49"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/50"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/51"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/52"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>GI and Other Associated</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/53/74"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/53/52">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/49"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/56"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/54">
    <bmdb:Title>TSP</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:54</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:54</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>TSP is an adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. TSP can bind to fibrinogen, fibronectin, laminin, type V collagen and integrins alpha-V/beta-1. It has been shown to play roles in platelet aggregation, angiogenesis, and tumorigenesis.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>TSP-1</bmdb:Alias>
    <bmdb:Alias>THBS1</bmdb:Alias>
    <bmdb:Alias>Thrombospondin-1</bmdb:Alias>
    <bmdb:Alias>THBS</bmdb:Alias>
    <bmdb:Alias>THBS-1</bmdb:Alias>
    <bmdb:Alias>thrombospondin-1p180</bmdb:Alias>
    <bmdb:AccessGrantedTo>Prostate and Urologic</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/54/75"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/54/22">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/127"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/54/23">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/286"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/66"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=11785"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P07996"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:7057"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/63">
    <bmdb:Title>PCA3</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:63</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:63</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>The prostate cancer antigen 3 (PCA3/DD3) gene is a highly specific biomarker upregulated in prostate cancer.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Gene</bmdb:Type>
    <bmdb:Alias>prostate cancer antigen 3</bmdb:Alias>
    <bmdb:Alias>DD3</bmdb:Alias>
    <bmdb:Alias>NCRNA00019</bmdb:Alias>
    <bmdb:Alias>non-protein coding RNA 19</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/63/81"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/64">
    <bmdb:Title>mesothelin</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:64</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:64</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Mesothelin, a cell surface antigen, was isolated using an antibody that reacts with ovarian cancers and mesotheliomas. Although the function of mesothelin is unknown, it may play a role in cellular adhesion and is present on mesothelium, mesotheliomas, and ovarian cancers. This gene encodes a preproprotein that is cleaved into two products, megakaryocyte potentiating factor and mesothelin. Alternative splicing results in multiple transcript variants.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Pre-pro-megakaryocyte-potentiating factor</bmdb:Alias>
    <bmdb:Alias>CAK1 antigen</bmdb:Alias>
    <bmdb:Alias>MSLN</bmdb:Alias>
    <bmdb:Alias>MPF</bmdb:Alias>
    <bmdb:Alias>CAK1</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/64/82"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/56">
    <bmdb:Title>hK2</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:56</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:56</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>The glandular kallikreins are a distinct group of serine proteases with molecular masses of 25,000 to 40,000. The glandular kallikrein gene family comprises 25 to 30 highly homologous genes that encode specific proteases involved in the processing of biologically active peptides (they cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin). Several human kallikrein genes have been isolated.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>KLK2</bmdb:Alias>
    <bmdb:Alias>kallikrein-related peptidase 2</bmdb:Alias>
    <bmdb:Alias>KLK2A2</bmdb:Alias>
    <bmdb:Alias>MGC12201</bmdb:Alias>
    <bmdb:Alias>glandular kallikrein 2</bmdb:Alias>
    <bmdb:Alias>kallikrein 2, prostatic</bmdb:Alias>
    <bmdb:Alias>Tissue kallikrein-2</bmdb:Alias>
    <bmdb:Alias>hGK-1</bmdb:Alias>
    <bmdb:Alias>Glandular kallikrein-1</bmdb:Alias>
    <bmdb:Alias>Kallikrein-2</bmdb:Alias>
    <bmdb:AccessGrantedTo>Prostate and Urologic</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/56/77"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/56/24">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/127"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/69"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/70"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/P20151"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6363"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6363"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/57">
    <bmdb:Title>hK4</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:57</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:57</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>
The glandular kallikreins are a distinct group of serine proteases with molecular masses of 25,000 to 40,000. Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Several human kallikrein genes have been isolated. hK4 is expressed in the prostate.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>Human kallikrein 4</bmdb:Alias>
    <bmdb:Alias>Kallikrein-4</bmdb:Alias>
    <bmdb:Alias>Prostase</bmdb:Alias>
    <bmdb:Alias>Kallikrein-like protein 1</bmdb:Alias>
    <bmdb:Alias>KLK-L1</bmdb:Alias>
    <bmdb:Alias>Enamel matrix serine proteinase 1</bmdb:Alias>
    <bmdb:Alias>Serine protease 17</bmdb:Alias>
    <bmdb:Alias>KLK4</bmdb:Alias>
    <bmdb:Alias>EMSP1</bmdb:Alias>
    <bmdb:Alias>PRSS17</bmdb:Alias>
    <bmdb:Alias>PSTS</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Prostate and Urologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/57/78"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/26">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/127"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/57/27">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/287"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/71"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/72"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6365"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9Y5K2"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:9622"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/62">
    <bmdb:Title>hk11</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:62</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:62</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>The glandular kallikreins are a distinct group of serine proteases with molecular masses of 25,000 to 40,000. Kallikreins are a subgroup of serine proteases having diverse physiological functions. hk11 is a possible multifunctional protease which efficiently cleaves &amp;apos;bz-Phe-Arg-4-methylcoumaryl-7-amide&amp;apos;, a kallikrein substrate, and weakly cleaves other substrates for kallikrein and trypsin. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Several human kallikrein genes have been isolated. Expressed in brain, skin and prostate. Isoform 1 is expressed preferentially in brain. Isoform 2 is expressed in prostate.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>KLK11</bmdb:Alias>
    <bmdb:Alias>kallikrein-related peptidase 11</bmdb:Alias>
    <bmdb:Alias>kallikrein 11</bmdb:Alias>
    <bmdb:Alias>TLSP</bmdb:Alias>
    <bmdb:Alias>PRSS20</bmdb:Alias>
    <bmdb:Alias>Hippostasin</bmdb:Alias>
    <bmdb:Alias>Serine protease 20</bmdb:Alias>
    <bmdb:Alias>Kallikrein-11</bmdb:Alias>
    <bmdb:AccessGrantedTo>Prostate and Urologic</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/62/80"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/62/29">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/287"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/79"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/80"/>
    <bmdb:referencesResource rdf:resource="http://www.genenames.org/data/hgnc_data.php?hgnc_id=6359"/>
    <bmdb:referencesResource rdf:resource="http://www.uniprot.org/uniprot/Q9UBX7"/>
    <bmdb:referencesResource rdf:resource="http://www.genome.jp/dbget-bin/www_bget?hsa:11012"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/65">
    <bmdb:Title>MMP7</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:65</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:65</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP&amp;apos;s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades proteoglycans, fibronectin, elastin and casein and differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The enzyme is involved in wound healing, and studies in mice suggest that it regulates the activity of defensins in intestinal mucosa. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>MPSL1</bmdb:Alias>
    <bmdb:Alias>matrix metalloproteinase 7 (matrilysin, uterine)</bmdb:Alias>
    <bmdb:Alias>PUMP-1</bmdb:Alias>
    <bmdb:Alias>Matrilysin</bmdb:Alias>
    <bmdb:Alias>Pump-1 protease</bmdb:Alias>
    <bmdb:Alias>Uterine metalloproteinase</bmdb:Alias>
    <bmdb:Alias>MMP-7</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/65/83"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/82"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/66">
    <bmdb:Title>IGFBP2</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:66</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:66</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Insulin-like growth factor binding protein 2 (IGFBP2) is overexpressed in ovarian malignant tissues and in the serum and cystic fluid of ovarian cancer patients, suggesting an important role of IGFBP2 in the biology of ovarian cancer.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>BP2</bmdb:Alias>
    <bmdb:Alias>IBP2</bmdb:Alias>
    <bmdb:Alias>Insulin-like growth factor-binding protein 2</bmdb:Alias>
    <bmdb:Alias>IGF-binding protein 2</bmdb:Alias>
    <bmdb:Alias>IGFBP-2</bmdb:Alias>
    <bmdb:Alias>IBP-2</bmdb:Alias>
    <bmdb:Alias>IGF-BP53</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/66/84"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/83"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/67">
    <bmdb:Title>SLPI</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:67</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:67</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>SLPI is a secreted inhibitor which protects epithelial tissues from serine proteases. It is found in various secretions including seminal plasma, cervical mucus, and bronchial secretions, and has affinity for trypsin, leukocyte elastase, and cathepsin G. Its inhibitory effect contributes to the immune response by protecting epithelial surfaces from attack by endogenous proteolytic enzymes; the protein is also thought to have broad-spectrum anti-biotic activity.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>HUSI-I</bmdb:Alias>
    <bmdb:Alias>ALK1</bmdb:Alias>
    <bmdb:Alias>ALP</bmdb:Alias>
    <bmdb:Alias>BLPI</bmdb:Alias>
    <bmdb:Alias>HUSI</bmdb:Alias>
    <bmdb:Alias>WAP4</bmdb:Alias>
    <bmdb:Alias>WFDC4</bmdb:Alias>
    <bmdb:Alias>secretory leukocyte protease inhibitor (antileukoproteinase)</bmdb:Alias>
    <bmdb:Alias>secretory leukocyte peptidase inhibitor</bmdb:Alias>
    <bmdb:Alias>antileukoproteinase</bmdb:Alias>
    <bmdb:Alias>MPI</bmdb:Alias>
    <bmdb:Alias>Seminal proteinase inhibitor</bmdb:Alias>
    <bmdb:Alias>WAP four-disulfide core domain protein 4</bmdb:Alias>
    <bmdb:Alias>Mucus proteinase inhibitor</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/67/85"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/84"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/68">
    <bmdb:Title>HEPC</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:68</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:68</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>HEPC (aka HAMP) is involved in the maintenance of iron homeostasis, and it is necessary for the regulation of iron storage in macrophages, and for intestinal iron absorption. The preproprotein is post-translationally cleaved into mature peptides of 20, 22 and 25 amino acids, and these active peptides are rich in cysteines, which form intramolecular bonds that stabilize their beta-sheet structures. These peptides exhibit antimicrobial activity. Mutations in this gene cause hemochromatosis type 2B, also known as juvenile hemochromatosis, a disease caused by severe iron overload that results in cardiomyopathy, cirrhosis, and endocrine failure.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>HAMP</bmdb:Alias>
    <bmdb:Alias>LEAP-1</bmdb:Alias>
    <bmdb:Alias>HFE2B</bmdb:Alias>
    <bmdb:Alias>LEAP1</bmdb:Alias>
    <bmdb:Alias>hepcidin antimicrobial peptide</bmdb:Alias>
    <bmdb:Alias>PLTR</bmdb:Alias>
    <bmdb:Alias>HEPCIDIN</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/68/86"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/69">
    <bmdb:Title>ITIH4</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:69</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:69</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>The inter-alpha-trypsin inhibitors (ITI) are a family of plasma protease inhibitors, assembled from a light chain - bikunin, encoded by AMBP - and five homologous heavy chains (encoded by ITIH1, ITIH2, ITIH3, ITIH4, and ITIH5), contributing to extracellular matrix stability by covalent linkage to hyaluronan. ITIH4 is secreted into the blood, where it is cleaved by plasma kallikrein into two smaller forms. Expression of the ITIH4 gene has been detected only in liver, and it seems to be upregulated during surgical trauma. This gene is part of a cluster of similar genes on chromosome 3. Two transcript variants encoding different isoforms have been found for this gene.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>IHRP</bmdb:Alias>
    <bmdb:Alias>H4P</bmdb:Alias>
    <bmdb:Alias>ITIHL1</bmdb:Alias>
    <bmdb:Alias>Inter-alpha-trypsin inhibitor heavy chain H4</bmdb:Alias>
    <bmdb:Alias>Inter-alpha-inhibitor heavy chain 4</bmdb:Alias>
    <bmdb:Alias>ITI heavy chain H4</bmdb:Alias>
    <bmdb:Alias>ITI-HC4</bmdb:Alias>
    <bmdb:Alias>Inter-alpha-trypsin inhibitor family heavy chain-related protein</bmdb:Alias>
    <bmdb:Alias> Plasma kallikrein sensitive glycoprotein 120</bmdb:Alias>
    <bmdb:Alias>PK-120</bmdb:Alias>
    <bmdb:Alias>Gp120</bmdb:Alias>
    <bmdb:Alias>PK120</bmdb:Alias>
    <bmdb:Alias>PRO1851</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/69/87"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/70">
    <bmdb:Title>CTAP-III</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:70</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:70</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>CTAP-III (officially named PPBP) is a platelet-derived growth factor that belongs to the CXC chemokine family. This growth factor is a potent chemoattractant and activator of neutrophils. It has been shown to stimulate various cellular processes including DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and sythesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by synovial cells.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>PPBP </bmdb:Alias>
    <bmdb:Alias>THBGB1</bmdb:Alias>
    <bmdb:Alias>SCYB7</bmdb:Alias>
    <bmdb:Alias>TGB</bmdb:Alias>
    <bmdb:Alias>NAP-2-L1</bmdb:Alias>
    <bmdb:Alias>LA-PF4</bmdb:Alias>
    <bmdb:Alias>MDGF</bmdb:Alias>
    <bmdb:Alias>LDGF</bmdb:Alias>
    <bmdb:Alias>Beta-TG</bmdb:Alias>
    <bmdb:Alias>CTAP3</bmdb:Alias>
    <bmdb:Alias>CXCL7</bmdb:Alias>
    <bmdb:Alias>PBP</bmdb:Alias>
    <bmdb:Alias>b-TG1</bmdb:Alias>
    <bmdb:Alias>TGB1</bmdb:Alias>
    <bmdb:Alias>CTAPIII</bmdb:Alias>
    <bmdb:Alias>NAP-2</bmdb:Alias>
    <bmdb:Alias>pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)</bmdb:Alias>
    <bmdb:Alias>platelet basic protein</bmdb:Alias>
    <bmdb:Alias>beta-thromboglobulin</bmdb:Alias>
    <bmdb:Alias>connective tissue-activating peptide III</bmdb:Alias>
    <bmdb:Alias>neutrophil-activating peptide-2</bmdb:Alias>
    <bmdb:Alias>TC1</bmdb:Alias>
    <bmdb:Alias>TC2</bmdb:Alias>
    <bmdb:Alias>B-TG1</bmdb:Alias>
    <bmdb:Alias>CXCL7</bmdb:Alias>
    <bmdb:Alias>THBGB</bmdb:Alias>
    <bmdb:Alias>thrombocidin 1</bmdb:Alias>
    <bmdb:Alias>thrombocidin 2</bmdb:Alias>
    <bmdb:Alias>CXC chemokine ligand 7</bmdb:Alias>
    <bmdb:Alias>thromboglobulin, beta-1</bmdb:Alias>
    <bmdb:Alias>small inducible cytokine B7</bmdb:Alias>
    <bmdb:Alias>leukocyte-derived growth factor</bmdb:Alias>
    <bmdb:Alias>low-affinity platelet factor IV</bmdb:Alias>
    <bmdb:Alias>neutrophil-activating peptide 2</bmdb:Alias>
    <bmdb:Alias>macrophage-derived growth factor</bmdb:Alias>
    <bmdb:Alias>small inducible cytokine subfamily B, member 7</bmdb:Alias>
    <bmdb:Alias>pro-platelet basic protein</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/70/88"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/71">
    <bmdb:Title>Spondin-2</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:71</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:71</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Spondin-2 is a cell adhesion protein that promotes adhesion and outgrowth of hippocampal embryonic neurons. It binds directly to bacteria and their components and functions as an opsonin for macrophage phagocytosis of bacteria. Spondin-2 is essential in the initiation of the innate immune response and represents a unique pattern-recognition molecule in the extacellular matrix for microbial pathogens. Spondin-2 also binds bacterial lipopolysaccharide.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>spondin 2</bmdb:Alias>
    <bmdb:Alias>SPON2</bmdb:Alias>
    <bmdb:Alias>DIL1</bmdb:Alias>
    <bmdb:Alias>DIL-1</bmdb:Alias>
    <bmdb:Alias>Mindin</bmdb:Alias>
    <bmdb:Alias>FLJ16313</bmdb:Alias>
    <bmdb:Alias>FLJ22401</bmdb:Alias>
    <bmdb:Alias>FLJ34460</bmdb:Alias>
    <bmdb:Alias>M-spondin</bmdb:Alias>
    <bmdb:Alias>spondin 2, extracellular matrix protein</bmdb:Alias>
    <bmdb:Alias>Differentially expressed in cancerous and non-cancerous lung cells 1</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/71/89"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/72">
    <bmdb:Title>transthyretin</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:72</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:72</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Transthyretin, one of the three prealbumins including alpha-1-antitrypsin, transthyretin and orosomucoid, is a carrier protein that transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. TT consists of a tetramer of identical subunits. More than 80 different mutations in this gene have been reported; most mutations are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart, and a small portion of the gene mutations is non-amyloidogenic. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis, and carpal tunnel syndrome.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>TT</bmdb:Alias>
    <bmdb:Alias>TTR</bmdb:Alias>
    <bmdb:Alias>prealbumin, amyloidosis type I</bmdb:Alias>
    <bmdb:Alias>PALB</bmdb:Alias>
    <bmdb:Alias>Prealbumin</bmdb:Alias>
    <bmdb:Alias>TBPA</bmdb:Alias>
    <bmdb:Alias>ATTR</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/72/90"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/73">
    <bmdb:Title>transferrin</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:73</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:73</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Transferrin, a glycoprotein with an approximate molecular weight of 76.5 kDa, is thought to have been created as a result of an ancient gene duplication event that led to generation of homologous C and N-terminal domains each of which binds one ion of ferric iron. The function of this protein is to transport iron from the intestine, reticuloendothelial system, and liver parenchymal cells to all proliferating cells in the body. This protein may also have a physiologic role as granulocyte/pollen-binding protein (GPBP) involved in the removal of certain organic matter and allergens from serum.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>TRF</bmdb:Alias>
    <bmdb:Alias>TF</bmdb:Alias>
    <bmdb:Alias>PRO1557</bmdb:Alias>
    <bmdb:Alias>PRO2086</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/73/91"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/74">
    <bmdb:Title>B2M</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:74</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:74</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>B2M is a component of the class I major histocompatibility complex (MHC) on the surface of nearly all nucleated cells and involved in the presentation of peptide antigens to the immune system. A mutation in this gene has been shown to result in hypercatabolic hypoproteinemia.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>beta-2-microglobulin</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/74/92"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/75">
    <bmdb:Title>APO-1</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:75</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:75</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>APO-1/FAS is a member of the TNF-receptor superfamily. This receptor contains a death domain. It has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. The interaction of this receptor with its ligand allows the formation of a death-inducing signaling complex that includes Fas-associated death domain protein (FADD), caspase 8, and caspase 10. This receptor has been also shown to activate NF-kappaB, MAPK3/ERK1, and MAPK8/JNK, and is found to be involved in transducing the proliferating signals in normal diploid fibroblast and T cells. At least eight alternatively spliced transcript variants have been described, some of which are candidates for nonsense-mediated decay (NMD). The isoforms lacking the transmembrane domain may negatively regulate the apoptosis mediated by the full length isoform.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>FAS</bmdb:Alias>
    <bmdb:Alias>CD95</bmdb:Alias>
    <bmdb:Alias>FAS1</bmdb:Alias>
    <bmdb:Alias>APT1</bmdb:Alias>
    <bmdb:Alias>TNFRSF6</bmdb:Alias>
    <bmdb:Alias>Fas (TNF receptor superfamily, member 6)</bmdb:Alias>
    <bmdb:Alias>APO</bmdb:Alias>
    <bmdb:Alias>tumor necrosis factor receptor superfamily, member 6</bmdb:Alias>
    <bmdb:Alias>FASTM</bmdb:Alias>
    <bmdb:Alias>ALPS1A</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/75/93"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/76">
    <bmdb:Title>eotaxin</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:76</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:76</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. Eotaxin displays chemotactic activity for eosinophils, but not mononuclear cells or neutrophils. This eosinophil specific chemokine assumed to be involved in eosinophilic inflammatory diseases such as atopic dermatitis, allergic rhinitis, asthma and parasitic infections.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>CCL11</bmdb:Alias>
    <bmdb:Alias>chemokine (C-C motif) ligand 11</bmdb:Alias>
    <bmdb:Alias>SCYA11</bmdb:Alias>
    <bmdb:Alias>eotaxin-1</bmdb:Alias>
    <bmdb:Alias>MGC22554</bmdb:Alias>
    <bmdb:Alias>small inducible cytokine subfamily A (Cys-Cys), member 11 (eotaxin)</bmdb:Alias>
    <bmdb:Alias>small inducible cytokine A11</bmdb:Alias>
    <bmdb:Alias>eosinophil chemotactic protein</bmdb:Alias>
    <bmdb:Alias>C-C motif chemokine 11</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/76/94"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/77">
    <bmdb:Title>MMP3</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:77</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:77</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP&amp;apos;s are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. MMP3 degrades fibronectin, laminin, collagens III, IV, IX, and X, and cartilage proteoglycans. The enzyme is thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>matrix metallopeptidase 3 (stromelysin 1, progelatinase)</bmdb:Alias>
    <bmdb:Alias>STMY1</bmdb:Alias>
    <bmdb:Alias>STMY</bmdb:Alias>
    <bmdb:Alias>Stromelysin-1</bmdb:Alias>
    <bmdb:Alias>SL-1</bmdb:Alias>
    <bmdb:Alias>Matrix metalloproteinase-3</bmdb:Alias>
    <bmdb:Alias>MMP-3</bmdb:Alias>
    <bmdb:Alias>Transin-1</bmdb:Alias>
    <bmdb:Alias>STR1</bmdb:Alias>
    <bmdb:Alias>CHDS6</bmdb:Alias>
    <bmdb:Alias>MGC126102</bmdb:Alias>
    <bmdb:Alias>MGC126103</bmdb:Alias>
    <bmdb:Alias>MGC126104</bmdb:Alias>
    <bmdb:Alias>proteoglycanase</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/77/95"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/78">
    <bmdb:Title>EGFR</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:78</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:78</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>EGFR is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncoge</bmdb:Alias>
    <bmdb:Alias>ERBB</bmdb:Alias>
    <bmdb:Alias>ERBB1</bmdb:Alias>
    <bmdb:Alias>Epidermal growth factor receptor</bmdb:Alias>
    <bmdb:Alias>Receptor tyrosine-protein kinase erbB-1</bmdb:Alias>
    <bmdb:Alias>c-erbB-1</bmdb:Alias>
    <bmdb:Alias>HER1</bmdb:Alias>
    <bmdb:Alias>mENA</bmdb:Alias>
    <bmdb:Alias>PIG61</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/78/96"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/79">
    <bmdb:Title>prolactin</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:79</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:79</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>There is increasing evidence that prolactin (PRL), a hormone/cytokine, plays a role in breast, prostate, and colorectal cancers via local production or accumulation. Elevated levels of serum PRL in ovarian and endometrial cancers have been reported, indicating a potential role for PRL in endometrial and ovarian carcinogenesis.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>PRL </bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/79/97"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/80">
    <bmdb:Title>leptin</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:80</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:80</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Leptin is secreted by white adipocytes and plays a major role in the regulation of body weight. This protein, which acts through the leptin receptor, functions as part of a signaling pathway that can inhibit food intake and/or regulate energy expenditure to maintain constancy of the adipose mass. Leptin has several endocrine functions and is also involved in the regulation of immune and inflammatory responses, hematopoiesis, angiogenesis and wound healing. Mutations in the leptin gene and/or its regulatory regions cause severe obesity and morbid obesity with hypogonadism. The leptin gene has also been linked to type 2 diabetes mellitus development.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>LEP</bmdb:Alias>
    <bmdb:Alias>OB</bmdb:Alias>
    <bmdb:Alias>OBS</bmdb:Alias>
    <bmdb:Alias>FLJ94114</bmdb:Alias>
    <bmdb:Alias>obesity factor</bmdb:Alias>
    <bmdb:Alias>leptin (murine obesity homolog)</bmdb:Alias>
    <bmdb:Alias>obese, mouse, homolog of</bmdb:Alias>
    <bmdb:Alias>leptin (obesity homolog, mouse)</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/80/98"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/81">
    <bmdb:Title>MIF</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:81</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:81</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>MIF, a lymphokine involved in cell-mediated immunity, immunoregulation, and inflammation, plays a role in the regulation of macrophage function in host defense through the suppression of anti-inflammatory effects of glucocorticoids. This lymphokine and the JAB1 protein form a complex in the cytosol near the peripheral plasma membrane, which may indicate an additional role in integrin signaling pathways. MIF is also closely related to tumorigenesis. </bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>GLIF</bmdb:Alias>
    <bmdb:Alias>GIF</bmdb:Alias>
    <bmdb:Alias>macrophage migration inhibitory factor (glycosylation-inhibiting factor)</bmdb:Alias>
    <bmdb:Alias>MMIF</bmdb:Alias>
    <bmdb:Alias>macrophage migration inhibitory factor</bmdb:Alias>
    <bmdb:Alias>phenylpyruvate tautomerase</bmdb:Alias>
    <bmdb:Alias>L-dopachrome tautomerase</bmdb:Alias>
    <bmdb:Alias>L-dopachrome isomerase</bmdb:Alias>
    <bmdb:Alias>Glycosylation-inhibiting factor</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Breast and Gynecologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/81/99"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/82">
    <bmdb:Title>IGF2</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:82</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:82</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>IGF2 is a member of the insulin family of polypeptide growth factors that is involved in development and growth. The IGF2 gene is an imprinted gene and is expressed only from the paternally inherited allele. It is a candidate gene for eating disorders. There is a read-through, INS-IGF2, which aligns to this gene at the 3&amp;apos; region and to the upstream INS gene at the 5&amp;apos; region. Alternatively spliced transcript variants, encoding either the same or different isoform, have been found for this gene. IGF2 is influenced by placental lactogen and may play a role in fetal development.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>FLJ44734</bmdb:Alias>
    <bmdb:Alias>C11orf43</bmdb:Alias>
    <bmdb:Alias>chromosome 11 open reading frame 43</bmdb:Alias>
    <bmdb:Alias>insulin-like growth factor 2 (somatomedin A)</bmdb:Alias>
    <bmdb:Alias>INSIGF</bmdb:Alias>
    <bmdb:Alias>pp9974</bmdb:Alias>
    <bmdb:Alias>FLJ22066</bmdb:Alias>
    <bmdb:Alias>Insulin-like growth factor II</bmdb:Alias>
    <bmdb:Alias>IGF-II</bmdb:Alias>
    <bmdb:Alias>Somatomedin-A</bmdb:Alias>
    <bmdb:Alias>PP1446</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/82/101"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/83">
    <bmdb:Title>galectin-3 ligand</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:83</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:83</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Galectin-3 is an endogenous lectin that binds glycan epitopes of cell membrane and some extracellular glycoproteins such as integrins and laminin. Galectin-3 is involved in several biological activities including regulation of cellular cycle, modulation of adhesion and tumor progression and metastasis. Serum galectin-3 ligands have been shown to modulate the immune reaction against tumors and viruses and their level increases in sera of several neoplastic diseases.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/83/102"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/84">
    <bmdb:Title>kininogen</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:84</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:84</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Kininogens are inhibitors of thiol proteases. The KNG1 gene uses alternative splicing to generate two different proteins- high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK). HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII. HMW-kininogen also inhibits the thrombin- and plasmin-induced aggregation of thrombocytes. LMW-kininogen inhibits the aggregation of thrombocytes. LMW-kininogen, in contrast to HMW-kininogen, is not involved in blood clotting.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>KNG1 </bmdb:Alias>
    <bmdb:Alias>kininogen 1</bmdb:Alias>
    <bmdb:Alias>KNG</bmdb:Alias>
    <bmdb:Alias>BDK</bmdb:Alias>
    <bmdb:Alias>alpha-2-thiol proteinase inhibitor</bmdb:Alias>
    <bmdb:Alias>bradykinin</bmdb:Alias>
    <bmdb:Alias>High molecular weight kininogen</bmdb:Alias>
    <bmdb:Alias>HMWK</bmdb:Alias>
    <bmdb:Alias>Williams-Fitzgerald-Flaujeac factor</bmdb:Alias>
    <bmdb:Alias>Fitzgerald factor</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/84/103"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/85">
    <bmdb:Title>AAT</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:85</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:85</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>Alpha-1-antitrypsin is secreted and is an extracellular serine protease inhibitor whose targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen activator. Defects in this gene can cause emphysema or liver disease. Elevation of alpha1-AT serum levels have been observed in the course of a large number of malignant diseases.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), membe</bmdb:Alias>
    <bmdb:Alias>SERPINA1 </bmdb:Alias>
    <bmdb:Alias>PI</bmdb:Alias>
    <bmdb:Alias>serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, anti</bmdb:Alias>
    <bmdb:Alias>A1A</bmdb:Alias>
    <bmdb:Alias>PI1</bmdb:Alias>
    <bmdb:Alias>alpha-1-antitrypsin</bmdb:Alias>
    <bmdb:Alias>A1AT</bmdb:Alias>
    <bmdb:Alias>MGC9222</bmdb:Alias>
    <bmdb:Alias>PRO2275</bmdb:Alias>
    <bmdb:Alias>MGC23330</bmdb:Alias>
    <bmdb:Alias>Alpha-1-antiproteinase</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/85/104"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/86">
    <bmdb:Title>GP73</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:86</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:86</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>The Golgi complex plays a key role in the sorting and modification of proteins exported from the endoplasmic reticulum. GP73 is a type II Golgi transmembrane protein. It processes proteins synthesized in the rough endoplasmic reticulum and assists in the transport of protein cargo through the Golgi apparatus. The expression of the GP73 gene has been observed to be upregulated in response to viral infection. Alternatively spliced transcript variants encoding the same protein have been described for this gene.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>golgi membrane protein 1</bmdb:Alias>
    <bmdb:Alias>GOLM1 </bmdb:Alias>
    <bmdb:Alias>GOLPH2</bmdb:Alias>
    <bmdb:Alias>C9orf155</bmdb:Alias>
    <bmdb:Alias>golgi phosphoprotein 2</bmdb:Alias>
    <bmdb:Alias>chromosome 9 open reading frame 155</bmdb:Alias>
    <bmdb:Alias>FLJ23608</bmdb:Alias>
    <bmdb:Alias>bA379P1.3</bmdb:Alias>
    <bmdb:Alias>FLJ22634</bmdb:Alias>
    <bmdb:Alias>PSEC0257</bmdb:Alias>
    <bmdb:Alias>bA379P1.3</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/86/105"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/87">
    <bmdb:Title>KRAS</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:87</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:87</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description>The KRAS gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>NS</bmdb:Alias>
    <bmdb:Alias>NS3</bmdb:Alias>
    <bmdb:Alias>KRAS1</bmdb:Alias>
    <bmdb:Alias>KRAS2</bmdb:Alias>
    <bmdb:Alias>RASK2</bmdb:Alias>
    <bmdb:Alias>KI-RAS</bmdb:Alias>
    <bmdb:Alias>C-K-RAS</bmdb:Alias>
    <bmdb:Alias>K-RAS2A</bmdb:Alias>
    <bmdb:Alias>K-RAS2B</bmdb:Alias>
    <bmdb:Alias>K-RAS4A</bmdb:Alias>
    <bmdb:Alias>K-RAS4B</bmdb:Alias>
    <bmdb:Alias>v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog</bmdb:Alias>
    <bmdb:Alias>c-K-ras2 protein</bmdb:Alias>
    <bmdb:Alias>oncogene KRAS2</bmdb:Alias>
    <bmdb:Alias>K-ras p21 protein</bmdb:Alias>
    <bmdb:Alias>c-Kirsten-ras protein</bmdb:Alias>
    <bmdb:Alias>PR310 c-K-ras oncogene</bmdb:Alias>
    <bmdb:Alias>transforming protein p21</bmdb:Alias>
    <bmdb:Alias>cellular c-Ki-ras2 proto-oncogene</bmdb:Alias>
    <bmdb:Alias>Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/87/106"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/88">
    <bmdb:Title>sVCAM-1</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:88</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:88</bmdb:URN>
    <bmdb:IsPanel>0</bmdb:IsPanel>
    <bmdb:Description></bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:Alias>http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&amp;Cmd=retrieve&amp;dopt=full_report&amp;l</bmdb:Alias>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/88/107"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/89">
    <bmdb:Title>Cramer 5-marker panel for ovarian cancer</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:89</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:89</bmdb:URN>
    <bmdb:IsPanel>1</bmdb:IsPanel>
    <bmdb:Description>The PLCO phase III specimens (test half) revealed marker panels produced only marginal improvement over CA 125 alone and, in some case, worse performance. Besides searching for new markers, some ways to improve detection might include: 1) Add epidemiologic variables, and 2) Add in prior markers values.
</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Protein</bmdb:Type>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/20"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/22"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/23"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/24"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/26"/>
    <bmdb:AccessGrantedTo>Curators</bmdb:AccessGrantedTo>
    <bmdb:AccessGrantedTo>Breast and Gynecologic</bmdb:AccessGrantedTo>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/89/108"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/89/56">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/119"/>
        </bmdb:BiomarkerStudyData>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/89/57">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/312"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/90">
    <bmdb:Title>Meltzer 3-marker panel for Esophageal Adenocarcinoma</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:90</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:90</bmdb:URN>
    <bmdb:IsPanel>1</bmdb:IsPanel>
    <bmdb:Description>Using real-time quantitative methylation-specific PCR, ten genes (HPP1, RUNX3, RIZ1, CRBP1, 3-OST-2, APC, TIMP3, p16, MGMT and p14) were screened for promoter hypermethylation in 77 esophageal adenocarcinoma, 93 Barrett&amp;apos;s Esophagus, and 64 normal esophagus specimens. p16, RUNX3 and HPP1 displayed increasing methylation frequencies in Barrett&amp;apos;s Esophagus vs. esophageal adenocarcinoma samples, with the increases in methylation occurring early, at the interface between Barrett&amp;apos;s Esophagus and low-grade dysplasia. Further study has shown that hypermethylation of p16 and HPP1 are independently associated with an increased risk of progression. In combined analyses, risk was detectable up to, but not earlier than, two years prededing neoplastic progression. Hypermethylation of p16, RUNX3 and HPP1 in Barrett&amp;apos;s Esophagus or low-grade dysplasia may represent independent risk factors for the progression of Barrett&amp;apos;s Esophagus to high-grade dysplasia or esophageal adenocarcinoma.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/48"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/49"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/50"/>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/90/109"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/90/53">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/56"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
  </bmdb:Biomarker>
  <bmdb:Biomarker rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/91">
    <bmdb:Title>Meltzer 3-marker panel with clinical features for Esophageal Adenocarcinoma</bmdb:Title>
    <bmdb:ShortName></bmdb:ShortName>
    <bmdb:BiomarkerID>urn:edrn:bmdb:biomarker:91</bmdb:BiomarkerID>
    <bmdb:URN>urn:edrn:bmdb:biomarker:91</bmdb:URN>
    <bmdb:IsPanel>1</bmdb:IsPanel>
    <bmdb:Description>Barrett&amp;apos;s esophagus predisposes to esophageal adenocarcinoma. This biomarker is part of a three-tiered risk stratification strategy, based on systematically selected epigenetic and clinical parameters, to improve Barrett&amp;apos;s esophagus surveillance efficiency.</bmdb:Description>
    <bmdb:QAState>Under Review</bmdb:QAState>
    <bmdb:Phase></bmdb:Phase>
    <bmdb:Security>Public</bmdb:Security>
    <bmdb:Type>Genomic</bmdb:Type>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/48"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/49"/>
    <bmdb:hasBiomarker rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/50"/>
    <bmdb:indicatorForOrgan rdf:resource="http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/91/110"/>
    <bmdb:hasBiomarkerStudyDatas>
        <bmdb:BiomarkerStudyData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/91/54">
          <bmdb:referencesStudy rdf:resource="http://edrn.nci.nih.gov/data/protocols/137"/>
          <bmdb:SensitivityDatas>
            <bmdb:SensitivityData rdf:about="http://edrn.jpl.nasa.gov/bmdb/biomarkers/studies/91/54/sensitivity-data-0">
              <bmdb:SensSpecDetail>Definition of Barrett&amp;apos;s esophagus progressor patients and specimens: Barrett&amp;apos;s esophagus progressor patients are Barrett&amp;apos;s esophagus subjects with either no dysplasia or low-grade dysplasia who later developed high-grade dysplasia or esophageal adenocarcinoma. Progressor specimens (any Barrett&amp;apos;s esophagus tissues obtained prior to the progression endpoint) were divided into three subgroups - those obtained at 0-2 years, 2-4 years or more than 4 years prior to the progression endpoint. Non-progressor specimens were defined as Barrett&amp;apos;s esophagus and low-grade dysplasia tissues obtained at 0-2 years, 2-4 years, or more than 4 years before the non-progression follow-up date.</bmdb:SensSpecDetail>
              <bmdb:Sensitivity>0</bmdb:Sensitivity>
              <bmdb:Specificity>0</bmdb:Specificity>
              <bmdb:Prevalence>0</bmdb:Prevalence>
              <bmdb:NPV></bmdb:NPV>
              <bmdb:PPV></bmdb:PPV>
            </bmdb:SensitivityData>
          </bmdb:SensitivityDatas>
        </bmdb:BiomarkerStudyData>
    </bmdb:hasBiomarkerStudyDatas>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/51"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/54"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/56"/>
    <bmdb:referencedInPublication rdf:resource="http://edrn.jpl.nasa.gov/bmdb/publications/view/81"/>
  </bmdb:Biomarker>
</rdf:RDF>
